TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: So far, several gene fusions for TFE3 have been identified in patients with tRCC, including ASPSCR1 (ASPL), PRCC, SFPQ (PSF), NONO, CLTC, DVL2, LUC7L3, PARP14, MED15, KHSRP, RBM10, ARID1B, MATR3, FUBP1, NEAT1, KAT6A, GRIPAP1, and EWSR13–11.